Anti-Inflammatory Effects of GPR55 Agonists and Antagonists in LPS-Treated BV2 Microglial Cells

• Egile Nagusiak: Lu Sun (Egilea), Matthias Apweiler (Egilea), Claus Normann (Egilea), Christoph W. Grathwol (Egilea), Thomas Hurrle (Egilea), Simone Gräßle (Egilea), Nicole Jung (Egilea), Stefan Bräse (Egilea), Bernd L. Fiebich (Egilea)
• Formatua: Liburua
• Argitaratua: MDPI AG, 2024-05-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Chronic inflammation is driven by proinflammatory cytokines such as interleukin 6 (IL-6), tumor necrosis factor-α (TNF-α), and chemokines, such as c-c motif chemokine ligand 2 (CCL2), CCL3, C-X-C motif chemokine ligand 2 (CXCL2), and CXCL10. Inflammatory processes of the central nervous system (CNS)...